Adare

Photo
Topics • Chemistry

The Evolution of the CDMO Industry

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine. CHEManager asked executives and industry experts from a broad range of CDMOs to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.

Photo
News

Adare to Expand Oral Dose Capabilities in Italy

US CDMO Adare Pharma Solutions is to add a high-shear mixer granulator at its Pessano, Italy facility, to complement existing fluid bed capabilities. The new mixer can provide wet granulation using either aqueous or organic-based solutions.

Photo
News

DSM in Talks to Take Adare Biome

DSM is in exclusive talks with US CDMO Adare Pharma Solutions to buy Adare Biome, a French developer and manufacture of postbiotics, for €275 million.

Top-Feature

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.